Avoro Capital Advisors LLC
Related Filers (51)
- IMMUNOMEDICS INC (48)
- Aghazadeh Behzad (36)
- Mirati Therapeutics, Inc. (16)
- IOVANCE BIOTHERAPEUTICS, INC. (9)
- Aadi Bioscience, Inc. (9)
- CymaBay Therapeutics, Inc. (8)
- AMICUS THERAPEUTICS, INC. (6)
- ACCELERON PHARMA INC (6)
- Avoro Ventures LLC (6)
- ALIMERA SCIENCES INC (5)
- MARINUS PHARMACEUTICALS, INC. (5)
- Xenon Pharmaceuticals Inc. (5)
- Adverum Biotechnologies, Inc. (4)
- FENNEC PHARMACEUTICALS INC. (4)
- PMV Pharmaceuticals, Inc. (4)
- MADRIGAL PHARMACEUTICALS, INC. (4)
- UNITED THERAPEUTICS Corp (4)
- Intec Pharma Ltd. (3)
- Teligent, Inc. (3)
- Monte Rosa Therapeutics, Inc. (3)
- Mersana Therapeutics, Inc. (3)
- Apellis Pharmaceuticals, Inc. (3)
- Oncobiologics, Inc. (2)
- TG THERAPEUTICS, INC. (2)
- BIODELIVERY SCIENCES INTERNATIONAL INC (2)
- Karyopharm Therapeutics Inc. (2)
- CONSTELLATION PHARMACEUTICALS INC (2)
- POINT Biopharma Global Inc. (2)
- Cue Biopharma, Inc. (2)
- IVERIC bio, Inc. (2)
- Athenex, Inc. (2)
- RELMADA THERAPEUTICS, INC. (2)
- IO Biotech, Inc. (2)
- ARENA PHARMACEUTICALS INC (2)
- AVADEL PHARMACEUTICALS PLC (2)
- Krystal Biotech, Inc. (2)
- Kymera Therapeutics, Inc. (2)
- Kura Oncology, Inc. (2)
- Ascendis Pharma A/S (2)
- PERNIX THERAPEUTICS HOLDINGS, INC. (1)
- AGENUS INC (1)
- VIVEVE MEDICAL, INC. (1)
- ASSEMBLY BIOSCIENCES, INC. (1)
- CATALYST BIOSCIENCES, INC. (1)
- Trillium Therapeutics Inc. (1)
- GENOCEA BIOSCIENCES, INC. (1)
- DICE Therapeutics, Inc. (1)
- Verrica Pharmaceuticals Inc. (1)
- Structure Therapeutics Inc. (1)
- BIOCRYST PHARMACEUTICALS INC (1)
- Spyre Therapeutics, Inc. (1)
- Show More ...
Other (44)
13F-HR
Wednesday, 2/14/2024
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 11/14/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/14/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/15/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 2/14/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/14/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/15/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/16/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 2/14/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
SC 14D9/A
Wednesday, 11/17/2021
Tender offer solicitation/recommendation statements filed under Rule 14d-9
13F-HR
Monday, 11/15/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
SC 14D9/A
Wednesday, 11/10/2021
Tender offer solicitation/recommendation statements filed under Rule 14d-9
SC 14D9
Thursday, 10/28/2021
Tender offer solicitation/recommendation statements filed under Rule 14d-9
SC14D9C
Thursday, 9/30/2021
Written communication by the subject company relating to a third party tender offer
13F-HR
Monday, 8/16/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/17/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 2/16/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/16/2020
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 8/14/2020
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 5/15/2020
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 2/14/2020
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 11/14/2019
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 8/14/2019
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 5/15/2019
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 2/14/2019
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 11/14/2018
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 8/14/2018
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 5/15/2018
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 2/14/2018
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 11/14/2017
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/14/2017
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/15/2017
Initial Quarterly Form 13F Holdings Report filed by institutional managers
CORRESP
Friday, 2/17/2017
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
13F-HR
Tuesday, 2/14/2017
Initial Quarterly Form 13F Holdings Report filed by institutional managers
CORRESP
Friday, 2/3/2017
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Tuesday, 11/29/2016
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
13F-HR
Monday, 11/14/2016
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/15/2016
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/16/2016
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 2/12/2016
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 11/13/2015
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 8/14/2015
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 5/15/2015
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 2/13/2015
Initial Quarterly Form 13F Holdings Report filed by institutional managers
Ownership (175)
SC 13G/A
Wednesday, 2/14/2024
Krystal Biotech, Inc.: Major Shareholders
SC 13G
Wednesday, 2/14/2024
Structure Therapeutics Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
AMICUS THERAPEUTICS, INC.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
PMV Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Mirati Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
MADRIGAL PHARMACEUTICALS, INC.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
IO Biotech, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
UNITED THERAPEUTICS Corp: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Kymera Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
CymaBay Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Mersana Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Apellis Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Xenon Pharmaceuticals Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Monte Rosa Therapeutics, Inc.: Major Shareholders
SC 13G
Wednesday, 2/14/2024
Spyre Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
MARINUS PHARMACEUTICALS, INC.: Major Shareholders
SC 13G
Wednesday, 2/14/2024
BIOCRYST PHARMACEUTICALS INC: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Ascendis Pharma A/S: Major Shareholders
SC 13G
Wednesday, 2/14/2024
Verrica Pharmaceuticals Inc.: Major Shareholders
4
Thursday, 9/14/2023
CymaBay Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/20/2023
Aadi Bioscience, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Tuesday, 2/14/2023
Monte Rosa Therapeutics, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
IVERIC bio, Inc.: Major Shareholders
SC 13G
Tuesday, 2/14/2023
Krystal Biotech, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
UNITED THERAPEUTICS Corp: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Mirati Therapeutics, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
IOVANCE BIOTHERAPEUTICS, INC.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
AMICUS THERAPEUTICS, INC.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Apellis Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
PMV Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Xenon Pharmaceuticals Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
MADRIGAL PHARMACEUTICALS, INC.: Major Shareholders
SC 13G
Tuesday, 2/14/2023
Kymera Therapeutics, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
MARINUS PHARMACEUTICALS, INC.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Kura Oncology, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Mersana Therapeutics, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Adverum Biotechnologies, Inc.: Major Shareholders
SC 13G
Tuesday, 2/14/2023
DICE Therapeutics, Inc.: Major Shareholders
SC 13G
Tuesday, 2/14/2023
Ascendis Pharma A/S: Major Shareholders
4
Monday, 1/30/2023
CymaBay Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Monday, 9/26/2022
Aadi Bioscience, Inc.: Major Shareholders
4
Monday, 9/26/2022
Aadi Bioscience, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/17/2022
Aadi Bioscience, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Friday, 2/11/2022
Monte Rosa Therapeutics, Inc.: Major Shareholders
SC 13G
Friday, 2/11/2022
IO Biotech, Inc.: Major Shareholders
SC 13G/A
Friday, 2/11/2022
POINT Biopharma Global Inc.: Major Shareholders
SC 13G
Friday, 2/11/2022
Apellis Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Friday, 2/11/2022
UNITED THERAPEUTICS Corp: Major Shareholders
SC 13G/A
Friday, 2/11/2022
Mirati Therapeutics, Inc.: Major Shareholders
SC 13G/A
Friday, 2/11/2022
ARENA PHARMACEUTICALS INC: Major Shareholders
SC 13G/A
Friday, 2/11/2022
FENNEC PHARMACEUTICALS INC.: Major Shareholders
SC 13G/A
Friday, 2/11/2022
Adverum Biotechnologies, Inc.: Major Shareholders
SC 13G
Friday, 2/11/2022
AMICUS THERAPEUTICS, INC.: Major Shareholders
SC 13G/A
Friday, 2/11/2022
MARINUS PHARMACEUTICALS INC: Major Shareholders
SC 13G/A
Friday, 2/11/2022
CymaBay Therapeutics, Inc.: Major Shareholders
SC 13G/A
Friday, 2/11/2022
AVADEL PHARMACEUTICALS PLC: Major Shareholders
SC 13G/A
Friday, 2/11/2022
Xenon Pharmaceuticals Inc.: Major Shareholders
SC 13G/A
Friday, 2/11/2022
IOVANCE BIOTHERAPEUTICS, INC.: Major Shareholders
SC 13G/A
Friday, 2/11/2022
RELMADA THERAPEUTICS, INC.: Major Shareholders
SC 13G/A
Friday, 2/11/2022
PMV Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Friday, 2/11/2022
MADRIGAL PHARMACEUTICALS, INC.: Major Shareholders
SC 13D/A
Wednesday, 11/24/2021
ACCELERON PHARMA INC: Major Shareholders
4
Tuesday, 11/23/2021
CymaBay Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D
Tuesday, 10/5/2021
ACCELERON PHARMA INC: Major Shareholders
SC 13D/A
Monday, 8/30/2021
Aadi Bioscience, Inc.: Major Shareholders
3
Monday, 8/30/2021
Aadi Bioscience, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 8/30/2021
Aadi Bioscience, Inc.: Statement of changes in beneficial ownership of securities
SC 13D
Friday, 6/4/2021
Aerpio Pharmaceuticals, Inc.: Major Shareholders
SC 13G
Friday, 2/12/2021
IVERIC bio, Inc.: Major Shareholders
SC 13G
Friday, 2/12/2021
Mersana Therapeutics, Inc.: Major Shareholders
SC 13G/A
Friday, 2/12/2021
Karyopharm Therapeutics Inc.: Major Shareholders
SC 13G/A
Friday, 2/12/2021
Cue Biopharma, Inc.: Major Shareholders
SC 13G/A
Friday, 2/12/2021
CONSTELLATION PHARMACEUTICALS INC: Major Shareholders
SC 13G/A
Friday, 2/12/2021
IOVANCE BIOTHERAPEUTICS, INC.: Major Shareholders
SC 13G
Friday, 2/12/2021
GENOCEA BIOSCIENCES, INC.: Major Shareholders
SC 13G
Friday, 2/12/2021
Trillium Therapeutics Inc.: Major Shareholders
SC 13G/A
Friday, 2/12/2021
Adverum Biotechnologies, Inc.: Major Shareholders
SC 13G/A
Friday, 2/12/2021
MARINUS PHARMACEUTICALS INC: Major Shareholders
SC 13G
Friday, 2/12/2021
ARENA PHARMACEUTICALS INC: Major Shareholders
SC 13G
Friday, 2/12/2021
MADRIGAL PHARMACEUTICALS, INC.: Major Shareholders
SC 13G
Friday, 2/12/2021
AVADEL PHARMACEUTICALS PLC: Major Shareholders
SC 13G
Friday, 2/12/2021
UNITED THERAPEUTICS Corp: Major Shareholders
SC 13G
Friday, 2/12/2021
RELMADA THERAPEUTICS, INC.: Major Shareholders
SC 13G/A
Friday, 2/12/2021
ALIMERA SCIENCES INC: Major Shareholders
SC 13G/A
Friday, 2/12/2021
Mirati Therapeutics, Inc.: Major Shareholders
SC 13G/A
Friday, 2/12/2021
Athenex, Inc.: Major Shareholders
SC 13G/A
Friday, 2/12/2021
Xenon Pharmaceuticals Inc.: Major Shareholders
SC 13G
Friday, 2/12/2021
Therapeutics Acquisition Corp.: Major Shareholders
SC 13G
Friday, 2/12/2021
Kura Oncology, Inc.: Major Shareholders
SC 13G/A
Friday, 2/12/2021
FENNEC PHARMACEUTICALS INC.: Major Shareholders
SC 13G
Friday, 2/12/2021
PMV Pharmaceuticals, Inc.: Major Shareholders
SC 13D/A
Friday, 10/23/2020
IMMUNOMEDICS INC: Major Shareholders
4
Friday, 10/23/2020
IMMUNOMEDICS INC: Statement of changes in beneficial ownership of securities
SC 13G
Tuesday, 9/1/2020
CymaBay Therapeutics, Inc.: Major Shareholders
3
Wednesday, 8/5/2020
CymaBay Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 6/22/2020
IMMUNOMEDICS INC: Statement of changes in beneficial ownership of securities
4
Friday, 5/1/2020
IMMUNOMEDICS INC: Statement of changes in beneficial ownership of securities
4
Friday, 3/20/2020
IMMUNOMEDICS INC: Statement of changes in beneficial ownership of securities
SC 13G/A
Monday, 2/24/2020
IOVANCE BIOTHERAPEUTICS, INC.: Major Shareholders
SC 13G
Friday, 2/14/2020
Cue Biopharma, Inc.: Major Shareholders
Proxies (18)
DFAN14A
Thursday, 3/2/2017
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Wednesday, 2/22/2017
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Tuesday, 2/14/2017
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Friday, 2/10/2017
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Tuesday, 2/7/2017
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Monday, 2/6/2017
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Wednesday, 2/1/2017
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Monday, 1/30/2017
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Thursday, 1/26/2017
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Wednesday, 1/18/2017
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Wednesday, 1/11/2017
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Wednesday, 1/11/2017
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Tuesday, 1/10/2017
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DEFC14A
Tuesday, 12/6/2016
Definitive proxy statement in connection with contested solicitations
PRRN14A
Tuesday, 11/29/2016
Revised preliminary proxy statement filed by non-management
DFAN14A
Tuesday, 11/29/2016
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Tuesday, 11/22/2016
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
PREC14A
Wednesday, 11/16/2016
Preliminary proxy statement in connection with contested solicitations